ATP2C1
Calcium-transporting ATPase type 2C member 1
Also known as: AT2C1_HUMAN, ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P98194
- Gene
- ATP2C1
- Ensembl
- ENSG00000017260
- Chromosome
- 3
- Canonical length
- 919 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene belongs to the family of P-type cation transport ATPases. This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the transport of calcium ions. Defects in this gene cause Hailey-Hailey disease, an autosomal dominant disorder. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
919 residues, UniProt reviewed canonical sequence.
>P98194|ATP2C1
1 MKVARFQKIP NGENETMIPV LTSKKASELP VSEVASILQA DLQNGLNKCE VSHRRAFHGW
61 NEFDISEDEP LWKKYISQFK NPLIMLLLAS AVISVLMHQF DDAVSITVAI LIVVTVAFVQ
121 EYRSEKSLEE LSKLVPPECH CVREGKLEHT LARDLVPGDT VCLSVGDRVP ADLRLFEAVD
181 LSIDESSLTG ETTPCSKVTA PQPAATNGDL ASRSNIAFMG TLVRCGKAKG VVIGTGENSE
241 FGEVFKMMQA EEAPKTPLQK SMDLLGKQLS FYSFGIIGII MLVGWLLGKD ILEMFTISVS
301 LAVAAIPEGL PIVVTVTLAL GVMRMVKKRA IVKKLPIVET LGCCNVICSD KTGTLTKNEM
361 TVTHIFTSDG LHAEVTGVGY NQFGEVIVDG DVVHGFYNPA VSRIVEAGCV CNDAVIRNNT
421 LMGKPTEGAL IALAMKMGLD GLQQDYIRKA EYPFSSEQKW MAVKCVHRTQ QDRPEICFMK
481 GAYEQVIKYC TTYQSKGQTL TLTQQQRDVY QQEKARMGSA GLRVLALASG PELGQLTFLG
541 LVGIIDPPRT GVKEAVTTLI ASGVSIKMIT GDSQETAVAI ASRLGLYSKT SQSVSGEEID
601 AMDVQQLSQI VPKVAVFYRA SPRHKMKIIK SLQKNGSVVA MTGDGVNDAV ALKAADIGVA
661 MGQTGTDVCK EAADMILVDD DFQTIMSAIE EGKGIYNNIK NFVRFQLSTS IAALTLISLA
721 TLMNFPNPLN AMQILWINII MDGPPAQSLG VEPVDKDVIR KPPRNWKDSI LTKNLILKIL
781 VSSIIIVCGT LFVFWRELRD NVITPRDTTM TFTCFVFFDM FNALSSRSQT KSVFEIGLCS
841 NRMFCYAVLG SIMGQLLVIY FPPLQKVFQT ESLSILDLLF LLGLTSSVCI VAEIIKKVER
901 SREKIQKHVS STSSSFLEVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP2C1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 81 nTPM
Expression across tissuesHPA
Tissue
- prostate: 81 nTPM
- parathyroid gland: 73 nTPM
- choroid plexus: 67 nTPM
- retina: 55 nTPM
- spinal cord: 52 nTPM
- cerebral cortex: 50 nTPM
Single-cell type
- prostatic glandular cells: 776 nCPM
- microglia: 541 nCPM
- sertoli cells: 505 nCPM
- hematopoietic stem cells: 497 nCPM
- platelets: 483 nCPM
- megakaryocyte-erythroid progenitors: 416 nCPM
Immune cell
- basophil: 31 nTPM
- eosinophil: 16 nTPM
- NK-cell: 12 nTPM
- non-classical monocyte: 9.6 nTPM
- myeloid DC: 9.5 nTPM
- T-reg: 9.3 nTPM
Brain region
- choroid plexus: 182 nTPM
- thalamus: 121 nTPM
- white matter: 117 nTPM
- cerebral cortex: 107 nTPM
- pons: 105 nTPM
- midbrain: 102 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP2C1.
Disease | AllUniProt
Conditions ATP2C1 is implicated in, by any mechanism.
- Hailey-Hailey disease (HHD) MIM:169600
Disease | GeneticClinVar
54 pathogenic / likely-pathogenic of 321 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Familial benign pemphigus
- Melanoma
ReferencesPubMed · IEDB
Publications for ATP2C1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris.
2019 · J Biol Chem · RCR 2.5 · 39 citations - Mechanisms of synergy of autoantibodies to M3 muscarinic acetylcholine receptor and secretory pathway Ca2+/Mn2+-ATPase isoform 1 in patients with non-desmoglein pemphigus vulgaris.
2020 · Int Immunopharmacol · RCR 1.1 · 15 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.18
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.67
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- calcium ion transmembrane transport
- calcium ion transport
- calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
- epidermis development
- Golgi calcium ion homeostasis
- Golgi calcium ion transport
- intracellular calcium ion homeostasis
- intracellular manganese ion homeostasis
- manganese ion transport
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of Golgi to plasma membrane protein transport
- trans-Golgi network membrane organization
Molecular functions
- ATP binding
- ATP hydrolysis activity
- calcium ion binding
- manganese ion binding
- metal ion binding
- P-type calcium transporter activity
- P-type manganese transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-type ATPase
- Cation-transporting P-type ATPase, N-terminal
- Cation-transporting P-type ATPase, C-terminal
- P-type ATPase, subfamily IIA, PMR1-type
- P-type ATPase, A domain superfamily
- P-type ATPase, phosphorylation site
- HAD superfamily
- P-type ATPase, transmembrane domain superfamily
- P-type ATPase, cytoplasmic domain N
- HAD-like superfamily
- P-type ATPase, haloacid dehalogenase domain
- P-type ATPase, A domain
- P-type ATPase actuator domain
- Cation transporting ATPase, C-terminus
- Cation transporter/ATPase, N-terminus
- P-type ATPase, cytoplasmic domain N
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP2C1 as an antibody target. Whether an autoantibody or antibody against ATP2C1 could matter depends on whether native ATP2C1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP2C1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATP2C1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...